Djeinam Touré
Datos Biográficos
| ID | 7015763 |
|---|---|
| NOMBRE | Djeinam Touré |
| NOMBRES | Djeinam |
| APELLIDO | Touré |
| FIRMA | TOURE D |
| AFILIACIONES | Helen Keller International |
| ORCID | 0000-0002-8392-1168 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2023 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Integration of azithromycin mass administration to 1–11-month-old children into an existing health platform to reduce child mortality
BACKGROUND: Azithromycin mass drug administration (MDA) to ages 1-59 months can reduce childhood mortality; however, more evidence is needed to support targeting a narrower age range of 1-11 months. This trial assesses the efficacy of azithromycin MDA to 1-11-month-old children in reducing mortality in a real-world setting with integration of vitamin A delivery within the established Child Health Days platform in Burkina Faso. METHODS: Mortalite …
Covid-19 concerns among caregivers and vitamin A supplementation coverage among children aged 6–59 months in four countries in Western sub-Saharan Africa
Objective: To assess child vitamin A supplementation (VAS) coverage in 2019 and 2020 and explore key factors, including COVID-19 concerns, that influenced VAS status in four sub-Saharan African countries. Design: Data from eight representative household surveys were used to assess VAS coverage. Multivariable logistic regression models examined the effect of rural/urban residence, child sex and age, caregiver education, COVID-19 concern and househ…
Sin obras prominentes en esta página.
Covid-19 concerns among caregivers and vitamin A supplementation coverage among children aged 6–59 months in four countries in Western sub-Saharan Africa
Objective: To assess child vitamin A supplementation (VAS) coverage in 2019 and 2020 and explore key factors, including COVID-19 concerns, that influenced VAS status in four sub-Saharan African countries. Design: Data from eight representative household surveys were used to assess VAS coverage. Multivariable logistic regression models examined the effect of rural/urban residence, child sex and age, caregiver education, COVID-19 concern and househ…
Integration of azithromycin mass administration to 1–11-month-old children into an existing health platform to reduce child mortality
BACKGROUND: Azithromycin mass drug administration (MDA) to ages 1-59 months can reduce childhood mortality; however, more evidence is needed to support targeting a narrower age range of 1-11 months. This trial assesses the efficacy of azithromycin MDA to 1-11-month-old children in reducing mortality in a real-world setting with integration of vitamin A delivery within the established Child Health Days platform in Burkina Faso. METHODS: Mortalite …
Child Nutrition and Water Access (2 obras) · Global Maternal and Child Health (2 obras) · Azithromycin (1 obras) · Child health (1 obras) · Cote d ivoire (1 obras) · COVID-19 Impact on Reproduction (1 obras) · Demography (1 obras) · Demography (1 obras) · Developing country (1 obras) · Health services research (1 obras)